Details for Patent: 9,387,208
✉ Email this page to a colleague
Which drugs does patent 9,387,208 protect, and when does it expire?
Patent 9,387,208 protects BRAFTOVI and is included in one NDA.
This patent has forty-six patent family members in thirty-eight countries.
Summary for Patent: 9,387,208
Title: | Pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-- pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate |
Abstract: | This invention relates to solid oral pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-- pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate (COMPOUND A) and the use of the formulations for treating proliferative diseases, such as solid tumor diseases. |
Inventor(s): | Verma; Daya (Edison, NJ), Krishnamachan; Yogita (Springfield, NJ), Shen; Xiaohong (Livingston, NJ), Lee; Hanchen (Teaneck, NJ), Li; Ping (Basking Ridge, NJ), Singh; Rajinder (Sewaren, NJ), Tan; LayChoo (Bridgewater, NJ) |
Assignee: | Novartis AG (Basel, CH) |
Application Number: | 14/359,121 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Process; Dosage form; |
Drugs Protected by US Patent 9,387,208
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE;ORAL | 210496-001 | Jun 27, 2018 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE;ORAL | 210496-002 | Jun 27, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,387,208
PCT Information | |||
PCT Filed | November 21, 2012 | PCT Application Number: | PCT/US2012/066185 |
PCT Publication Date: | May 30, 2013 | PCT Publication Number: | WO2013/078264 |
International Family Members for US Patent 9,387,208
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 088936 | ⤷ Try a Trial | |||
Australia | 2012340759 | ⤷ Try a Trial | |||
Brazil | 112014011981 | ⤷ Try a Trial | |||
Canada | 2856406 | ⤷ Try a Trial | |||
Chile | 2014001337 | ⤷ Try a Trial | |||
China | 103945831 | ⤷ Try a Trial | |||
China | 105708819 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |